Accretion Pharmaceuticals Limited (NSE:ACCPL)
India · Delayed Price · Currency is INR 119.40
+2.30 (1.96%)
At close: May 26, 2026
Accretion Pharmaceuticals Market Cap
Accretion Pharmaceuticals has a market cap or net worth of 1.31 billion as of May 27, 2026.
Market Cap
1.31B
Enterprise Value
1.39B
Revenue
898.18M
Ranking
n/a
PE Ratio
13.01
Stock Price
119.40
Market Cap Chart
Since May 21, 2025, Accretion Pharmaceuticals's market cap has increased from 922.07M to 1.31B, an increase of 41.59%. That is a compound annual growth rate of 40.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 1.33B | 35.91% |
| Dec 31, 2025 | 976.54M | 5.91% |
| May 21, 2025 | 922.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Parnax Lab | 1.70B |
| Coral Laboratories | 1.66B |
| Aayush Wellness | 1.55B |
| Lactose (India) | 1.53B |
| Bilcare | 1.51B |
| Bal Pharma | 1.30B |
| Concord Drugs | 1.02B |
| Pharmaids Pharmaceuticals | 1.01B |